463 related articles for article (PubMed ID: 19195685)
61. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
Brouns R; Heylen E; Sheorajpanday R; Willemse JL; Kunnen J; De Surgeloose D; Hendriks DF; De Deyn PP
Clin Neurol Neurosurg; 2009 Feb; 111(2):165-70. PubMed ID: 18980797
[TBL] [Abstract][Full Text] [Related]
62. Prothrombotic gene mutations and Crohn's disease; is there any association?
Over-Hamzaoglu H; Abaci N; Türe F; Alkim C; Tezel A; Avsar E; Tözün N
Hepatogastroenterology; 2005; 52(65):1467-9. PubMed ID: 16201098
[TBL] [Abstract][Full Text] [Related]
63. Thrombophilia and risk of venous thrombosis in patients with cancer.
Decousus H; Moulin N; Quenet S; Bost V; Rivron-Guillot K; Laporte S; Mismetti P
Thromb Res; 2007; 120 Suppl 2():S51-61. PubMed ID: 18023713
[TBL] [Abstract][Full Text] [Related]
64. G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.
Sartori M; Favaretto E; Legnani C; Cini M; Conti E; Pili C; Palareti G
Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):113-7. PubMed ID: 19356951
[TBL] [Abstract][Full Text] [Related]
65. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
66. Hereditary thrombophilia in ethnic Omani patients.
Pathare A; Al Kindi S; Al Haddabi H; Dennison D; Bayoumi R; Muralitharan S
Am J Hematol; 2006 Feb; 81(2):101-6. PubMed ID: 16432849
[TBL] [Abstract][Full Text] [Related]
67. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients.
Abdelkefi A; Ben Romdhane N; Kriaa A; Chelli M; Torjman L; Ladeb S; Ben Othman T; Lakhal A; Guermazi S; Ben Hassen A; Ladeb F; Ben Abdeladhim A
Bone Marrow Transplant; 2005 Nov; 36(10):885-9. PubMed ID: 16151418
[TBL] [Abstract][Full Text] [Related]
68. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
[TBL] [Abstract][Full Text] [Related]
69. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
Bedencic M; Bozic M; Peternel P; Stegnar M
Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
[TBL] [Abstract][Full Text] [Related]
70. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
71. Inherited thrombophilia and venous thromboembolism.
Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
[TBL] [Abstract][Full Text] [Related]
72. Management options for thrombophilias.
Gallus AS
Semin Thromb Hemost; 2005 Feb; 31(1):118-26. PubMed ID: 15706484
[TBL] [Abstract][Full Text] [Related]
73. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
Glueck CJ; Tracy T; Wang P
J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
[TBL] [Abstract][Full Text] [Related]
74. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients.
de Paula Sabino A; Ribeiro DD; Carvalho Md; Cardoso J; Dusse LM; Fernandes AP
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):271-5. PubMed ID: 16651869
[TBL] [Abstract][Full Text] [Related]
75. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
[TBL] [Abstract][Full Text] [Related]
76. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
[TBL] [Abstract][Full Text] [Related]
77. Arterial thrombosis and the role of thrombophilia.
Boekholdt SM; Kramer MH
Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
[TBL] [Abstract][Full Text] [Related]
78. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
Eroglu A; Egin Y; Cam R; Akar N
Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
[TBL] [Abstract][Full Text] [Related]
79. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
Rossi E; Za T; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
